These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 7984887

  • 21. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R.
    Fortschr Med; 1994 Jan 20; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract] [Full Text] [Related]

  • 22. [Reflux esophagitis. Step-down instead of step-up].
    MMW Fortschr Med; 2006 Nov 23; 148(47):56-7. PubMed ID: 17168191
    [No Abstract] [Full Text] [Related]

  • 23. Safety and efficacy of rabeprazole in gastroesophageal reflux disease: report of a multicenter study.
    Kar P, Chandrashekar N, Devi S, Bhatia SJ, Alvares JF, Taneja A, Towar A.
    Indian J Gastroenterol; 2003 Nov 23; 22(4):153. PubMed ID: 12962446
    [No Abstract] [Full Text] [Related]

  • 24. [Inhibitors of proton pump in the treatment of non-ulcer functional dyspepsia of the reflux-like type].
    Ivanova NG.
    Eksp Klin Gastroenterol; 2002 Nov 23; (2):35-6, 101. PubMed ID: 12046384
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA, Ramírez-Barba EJ, Ramírez-Covarrubias JC.
    Rev Gastroenterol Mex; 1996 Nov 23; 61(4):306-9. PubMed ID: 9072780
    [Abstract] [Full Text] [Related]

  • 27. [Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].
    Wilson BV, Knudsen T.
    Ugeskr Laeger; 1996 Mar 18; 158(12):1695-7. PubMed ID: 8644421
    [No Abstract] [Full Text] [Related]

  • 28. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R.
    J Gastroenterol Hepatol; 1996 Oct 18; 11(10):897-9. PubMed ID: 8912122
    [No Abstract] [Full Text] [Related]

  • 29. Reflux oesophagitis and its treatment.
    Long RG.
    Br J Clin Pract Suppl; 1994 Oct 18; 75():36-9; discussion 40. PubMed ID: 8060800
    [No Abstract] [Full Text] [Related]

  • 30. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Oct 18; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 31. Clinical review of lansoprazole.
    Lockhart SP.
    Br J Clin Pract Suppl; 1994 Oct 18; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [Abstract] [Full Text] [Related]

  • 32. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 18; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 33. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.
    Am J Gastroenterol; 1997 Sep 18; 92(9):1475-9. PubMed ID: 9317066
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Sep 18; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 36. [The proton pump especially steady in grip. Fast help for nightly reflux complaints].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):39. PubMed ID: 14974330
    [No Abstract] [Full Text] [Related]

  • 37. Balanced perspective essential in erosive oesophagitis treatment.
    Gillessen A.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):889-90; author reply 890-1. PubMed ID: 16225500
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of acid peptic disease: focus on proton pump inhibitors. Proceedings of the 1st International Symposium on Lansoprazole. Athens, Greece, 24 September 1992.
    Aliment Pharmacol Ther; 1993 Nov 01; 7 Suppl 1():1-75. PubMed ID: 8098225
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [A case of the successful treatment of the esophageal leukoplakia with rabeprazole].
    Arutiunov AG, Burkov SG, Burdina EG, Svirchev VV.
    Eksp Klin Gastroenterol; 2002 Nov 01; (4):38-9, 131. PubMed ID: 12503273
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.